Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate

被引:54
作者
Roussanne, MC
Lieberherr, M
Souberbielle, JC
Sarfati, E
Drüeke, T
Bourdeau, A
机构
[1] Hop Necker Enfants Malad, INSERM, U507, F-75015 Paris, France
[2] Hop Necker Enfants Malad, Dept Nephrol, Paris, France
[3] CNRS, Jouy En Josas, France
[4] Hop Necker Enfants Malad, Dept Physiol, Paris, France
[5] Hop St Louis, Paris, France
关键词
calcium-sensing receptor; cell growth; human parathyroid cells; intracellular calcium; PTH secretion;
D O I
10.1046/j.1365-2362.2001.00809.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background It remains uncertain how calcium, phosphate and calcitriol regulate parathyroid cell growth. The present study was aimed at examining possible direct effects of these modulators and of the calcimimetic NPS R-467 on parathyroid cell growth in vitro. Materials and methods Cell proliferation was determined by [H-3]thymidine incorporation and cell cycle antigen Ki 67 expression in a parathyroid cell culture model derived from uraemic patients. The effect of NPS R-467 on parathyroid hormone (PTH) secretion and intracellular [Ca2+](i) response was also examined. Results Increasing the [Ca2+] in the medium from 0.5 to 1.7 mM increased DNA synthesis (P < 0.005) and the number of Ki 67-positive cells (P < 0.005). However, NPS R-467 (0.01-1 muM) inhibited (3)[H]thymidine incorporation by 35% in the presence of 0.5 mM [Ca2+](e). Exposure of cells to Ca2+ or NPS R-467 led to a rapid increase of intracellular Ca2+, although the pattern of increase differed. Addition of calcitriol (10(-10)-10(-7) M) to the culture medium suppressed [H-3]thymidine incorporation dose-dependently. Finally, high levels of phosphate (3.5 mM) in the medium led to a significant (P < 0.05) increase in [H-3]thymidine incorporation. Conclusion The observed stimulatory effect of Ca2+ in the medium in vitro appears to be at variance with the inhibitory effect of calcimimetic NPS R-467 in vitro. In an attempt to solve these apparent discrepancies, and based on the notion of a reduced calcium-sensing receptor (CaR) expression in parathyroid tissues of uraemic patients, we hypothesize that Ca2+ may regulate parathyroid cell proliferation via two different pathways, with predominant growth inhibition in cases of high CaR expression or activation, but prevailing stimulation of proliferation in cases of low CaR expression.
引用
收藏
页码:610 / 616
页数:7
相关论文
共 34 条
[1]
Vitamin D and the parathyroid [J].
Beckerman, P ;
Silver, J .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 317 (06) :363-369
[2]
BRANDI M, 1987, CALCIUM REGULATION B, P238
[3]
BOVINE PARATHYROID CELLS - CULTURES MAINTAINED FOR MORE THAN 140 POPULATION DOUBLINGS [J].
BRANDI, ML ;
FITZPATRICK, LA ;
COON, HG ;
AURBACH, GD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1709-1713
[4]
Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate [J].
Brown, AJ ;
Ritter, CS ;
Finch, JL ;
Slatopolsky, EA .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1284-1292
[5]
BROWN EM, 1987, RECENT PROG HORM RES, V43, P337
[6]
CLONING AND CHARACTERIZATION OF AN EXTRACELLULAR CA2+-SENSING RECEPTOR FROM BOVINE PARATHYROID [J].
BROWN, EM ;
GAMBA, G ;
RICCARDI, D ;
LOMBARDI, M ;
BUTTERS, R ;
KIFOR, O ;
SUN, A ;
HEDIGER, MA ;
LYTTON, J ;
HEBERT, SC .
NATURE, 1993, 366 (6455) :575-580
[7]
Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas [J].
Chikatsu, N ;
Fukumoto, S ;
Takeuchi, Y ;
Suzawa, M ;
Obara, T ;
Matsumoto, T ;
Fujita, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) :7553-7557
[8]
Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism [J].
Gogusev, J ;
Duchambon, P ;
Hory, B ;
Giovannini, M ;
Goureau, Y ;
Sarfati, E ;
Drueke, TB .
KIDNEY INTERNATIONAL, 1997, 51 (01) :328-336
[9]
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[10]
Hammerland LG, 1998, MOL PHARMACOL, V53, P1083